A case of biopsy-proven cardiac sarcoidosis without any other extracardiac manifestations  by Ikeuchi, Masaki et al.
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Summary  A  49-year-old  woman  was  referred  to  our  hospital  for  uncontrollable  heart  fail-
ure. She  had  never  been  diagnosed  as  having  sarcoidosis.  Chest  X-ray  showed  cardiomegaly
without bilateral  hilar  lymphadenopathy.  Echocardiography  showed  diffuse  hypokinesis  of  the
left ventricle  mimicking  idiopathic  dilated  cardiomyopathy.  No  speciﬁc  manifestations  imply-
ing sarcoidosis  were  observed.  On  cardiac  catheterization,  coronary  angiograms  were  normal,
whereas  concurrent  routine  endomyocardial  biopsy  showed  foci  of  non-caseating  granuloma,
indicating  sarcoidosis.  Pathological  ﬁnding  was  the  only  clue  to  diagnose  cardiac  sarcoidosis
among our  standard  examinations  for  heart  failure.  No  other  additional  investigations  found
any extracardiac  features  of  sarcoidosis.  All  serological  and  immunological  examinations  were
within normal  range.  This  is  a  challenging  case  of  biopsy-proven  cardiac  sarcoidosis  without  any
other extracardiac  involvement.
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ntroductionardiac  involvement  in  patients  with  sarcoidosis  (cardiac
arcoidosis)  is  associated  with  poor  prognosis.  Appropriate
herapies  may  prevent  the  progression  of  the  involvement,
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ut  early  and  precise  diagnosis  is  still  challenging.  A  report
f  320  autopsied  cases  of  sarcoidosis  in  Japan  [1]  revealed
hat  mortality  relating  to  cardiac  sarcoidosis  was  found  in
50  cases  of  the  194  sarcoidosis-related  deaths,  but  an
nte  mortem  clinical  diagnosis  had  been  made  in  only  40
ases  (26.7%).  One  of  the  major  problems  that  make  diag-
osis  difﬁcult  is  that  no  conventional  imaging  techniques
re  sensitive  enough  to  detect  myocardial  involvement.
 more  serious  one  is  that  some  of  the  patients  have
ardiac-predominant  disease  without  any  other  character-
stic  extracardiac  features  [2].  We  report  such  a challenging
 Published by Elsevier Ltd. All rights reserved.
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Figure  1  (A)  Chest  X-ray  showed  cardiomegaly.  Bilateral  hilar  lymphadenopathy  was  not  observed.  (B)  12  lead  electrocardiograms
(ECG) and  echocardiographic  data  recorded  on  admission  and  3  years  after.  An  ECG  on  admission  (left  panels)  demonstrated  sinus
rhythm with  heart  rate  of  78  bpm,  left  axis  deviation,  abnormal  Q  in  V1—3,  and  intraventricular  conduction  disturbance  with  conﬁg-
uration of  complete  right  bundle  branch  block  (QRS  width:  152  ms).  No  signiﬁcant  change  occurred  during  3  years.  LV,  left  ventricle;
EDd, end-diastolic  dimension;  EDs,  end-systolic  dimension;  EF,  ejection  fraction.
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Figure  2  Hematoxylin-eosin  staining  of  the  myocardium  from
ventricular  septum  showed  foci  of  non-caseating  granuloma  in
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ase  of  biopsy-proven  cardiac-predominant  sarcoidosis  with-
ut  any  other  extracardiac  manifestations.
ase report
 49-year-old  Japanese  woman  was  referred  to  our  hos-
ital  for  uncontrollable  heart  failure.  She  complained  of
rogressive  fatigue  and  dyspnea  on  effort.  She  had  never
een  diagnosed  with  sarcoidosis.  On  physical  examination,
lood  pressure  was  114/82  mm  Hg  and  pulse  was  regular
ith  74  bpm.  Her  height  was  151.5  cm  and  weight  58.9  kg.
er  New  York  Heart  Association  (NYHA)  class  was  III.  Her
reath  sounds  were  normal.  She  had  an  abnormal  third
eart  sound,  but  no  murmurs.  No  obvious  pretibial  or  facial
dema  was  noted.  Chest  X-ray  showed  cardiomegaly  with
 cardiothoracic  ratio  of  0.55  without  bilateral  hilar  lym-
hadenopathy  (Fig.  1A).  A  12-lead  electrocardiogram  (ECG)
howed  normal  sinus  rhythm,  left  axis  deviation,  abnor-
al  Q  in  V1—3,  and  intraventricular  conduction  disorder
QRS  width:  152  ms;  Fig.  1B,  left  panels).  A  holter  ECG
onitoring  during  24  h  showed  2274  beats  of  ventricular
remature  contraction  with  one  triplet.  No  atrioventricular
lock  was  seen.  Two-dimensional  echocardiography  showed
nlarged  left  ventricle  (LV);  end-diastolic  dimension  (EDD)
as  67  mm.  Diffuse  hypokinesis  of  the  LV  with  ejection  frac-
ion  (EF)  of  34%  was  shown  without  thinning  of  the  LV  wall.
n  laboratory  data,  serum  brain  natriuretic  peptide  was
ncreased  to  254  pg/ml.
Getting  well  due  to  standard  therapy  for  heart  fail-
re,  she  underwent  cardiac  catheterization.  Right  heart
atheterization  revealed  normal  pulmonary  capillary  wedge
ressure  (mean:  4  mm  Hg)  and  slightly  reduced  cardiac  index
2.18  l/min/m2).  Coronary  angiograms  were  normal,  but  left
entriculography  showed  a  diffuse  reduction  in  LV  motion
specially  at  the  anterolateral  and  apical  wall.  Concurrent
yocardial  biopsy  of  the  right  ventricular  (RV)  septum  was
one  routinely  for  investigation  of  LV  dysfunction,  and  then
istological  ﬁndings  showed  foci  of  non-caseating  granuloma
n  the  subendothelial  layer  and  interstitial  tissue,  indicating
ardiac  sarcoidosis  (Fig.  2).
After  diagnosing  sarcoidosis  histopathologically,  we
ssessed  severity  and  range  of  the  organ  involvement.  First,
everity  of  the  cardiac  involvement  was  estimated.  Myocar-
ial  scintigraphy  using 201Tl-Cl  showed  patchy  persisting
erfusion  defect  in  the  heart  (Fig.  3A).  Cardiac  magnetic
esonance  imaging  with  gadolinium  enhancement  repre-
ented  delayed  myocardial  enhancement  strongly  in  the
eptal,  and  also  in  anterior,  inferior,  and  posterior  wall  of
V  (Fig.  3B).  On  the  other  hand,  screening  of  extracardiac
esions  by  chest  CT  could  not  point  out  hilar  or  mediasti-
al  lymphadenopathy.  Abdominal  echography  and 67gallium
cintigraphy  (Fig.  3C)  also  demonstrated  almost  normal  ﬁnd-
ngs.  Pulmonary  function  test  was  normal  (%vital  capacity
15.2%,  forced  expiratory  volume  1.0%  88.47%).  Cutaneous
nd  ophthalmologic  complications  were  denied  by  each  spe-
ialist.  All  serological  examinations,  the  concentration  of
gG  (1450  mg/dl),  angiotensin-converting  enzyme  (13.5  U/l),
nd  lysozyme  (7.6  g/ml)  were  within  the  normal  range.
uberculin  skin  testing  was  positive.
She  had  received  standard  medication  for  heart  failure
ith  furosemide,  spironolactone,  imidapril,  carvedilol,  and
s
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bhe subendothelial  layer  and  interstitial  tissue  (arrows).  Scale
ar, 100  m.
igitalis.  Then,  we  added  prednisolone  to  prevent  progres-
ion  of  sarcoidosis.  Initial  dose  was  30  mg,  and  gradually
apered.  Steroid  therapy  did  not  worsen  the  state  of  heart
ailure.  When  the  patient  was  discharged,  her  NYHA  func-
ional  class  was  improved  to  II.
Three  years  later,  steroid  therapy  (prednisolone
 mg/day)  is  continuing.  Repeated  ECG  and  echocardio-
rams  showed  no  remarkable  changes  (Fig.  1B).  She  is
lmost  ﬁne  and  preserved  the  activity  of  daily  life  by
erself.
iscussion
ardiac  sarcoidosis  is  clinically  important  because  of  poor
rognosis  and  relatively  high  risk  of  sudden  death.  In  Japan,
his  disease  is  more  common  than  in  the  West  [3]  and  respon-
ible  for  as  many  as  85%  of  deaths  from  sarcoidosis  [4].
n  the  other  hand,  it  has  been  reported  that  steroids  sup-
ress  inﬂammation  and  progression  of  ﬁbrosis  leading  to
igniﬁcant  improvement  in  survival  [5].  Therefore,  early
ecognition  of  cardiac  involvement  is  crucial.  But  ante
ortem  diagnosis  of  cardiac  involvement  has  been  difﬁcult,
ecause  clinical  manifestations  are  often  non-speciﬁc,  and
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Figure  3  (A)  Myocardial  scintigraphy  with 201Tl-Cl  showed  perfusion  defect  at  anteroseptal,  septal,  and  apical  wall.  (B)  Cardiac
magnetic resonance  imaging  with  gadolinium  enhancement  represented  delayed  myocardial  enhancement  most  strongly  in  the
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pseptal, and  also  in  anterior,  inferior,  and  posterior  wall  of  LV  (a
ventricle; RV,  right  ventricle.
sensitivity  and  speciﬁcity  of  cardiac  modalities  are  limited.
A  more  serious  problem  is  that  approximately  5%  of  patients
would  have  cardiac-predominant  disease  and  present  with-
out  major  characteristic  extracardiac  features  [2].  In  such
cases,  it  is  hard  to  recognize  the  real  etiology  of  their  failed
hearts.
In  our  case,  her  clinical  manifestation  on  ﬁrst  admis-
sion  was  heart  failure  with  LV  systolic  dysfunction  mimicking
idiopathic  dilated  cardiomyopathy.  General  physiological
ﬁndings  and  standard  examinations  for  heart  failure  did
not  imply  sarcoidosis  at  all.  Therefore,  in  her  clinical
course,  routine  endomyocardial  biopsy  was  the  only  chance
to  diagnose  her  disease  precisely.  In  general,  biopsy  is
a  conventional  and  speciﬁc  method  to  diagnose  cardiac
o
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hs).  (C) 67Gallium  scintigraphy  showed  negative  ﬁnding.  LV,  left
arcoidosis,  but  may  lack  sensitivity  as  a  result  of  sam-
ling  error,  because  cardiac  inﬁltration  is  usually  patchy
nd  focal  [6].  In  our  case,  broad  and  severe  inﬁltration
o  RV  septum,  as  our  cardiac  magnetic  resonance  imag-
ng  (MRI)  clearly  showed,  might  fortunately  support  us  to
et  affected  tissues.  To  detect  such  a  clinically  challenging
isease  as  precisely  as  possible,  a  more  sensitive  and  system-
tic  strategy  must  be  established.  Nowadays,  new  imaging
echniques,  such  as  cardiac  MRI  [7]  and  ﬂuorodeoxyglucose
ositron  emission  tomography  (18F-FDG-PET)  [8],  are  devel-
ping.  Cardiac  MRI  was  useful  for  us  even  after  diagnosis
istopathologically,  because  it  could  let  us  know  the  range  of
nvolvement.  But,  if  performed  earlier,  those  images  would
ave  played  a  much  more  crucial  role  for  the  process  of
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iagnosis. 18F-FDG-PET  might  also  have  provided  more  accu-
ate  information  about  her  illness,  because  it  is  reported
o  be  more  sensitive  to  scan  not  only  cardiac  sarcoidosis
ut  also  systemic  lesions  than 67gallium  scintigraphy  [9].
 recent  report  suggested  the  usefulness  of  chest  CT  scan
o  detect  mediastinal  lymphadenopathy  [10], whereas  her
ymph  nodes  were  almost  normal.  It  is  sure  that  possibili-
ies  of  minimal  extracardiac  invasions  were  not  completely
enied  by  our  available  investigations.  However,  there  may
e  additional  supporting  evidence  that  no  newly  develop-
ng  lesions  have  been  detected  outside  of  her  heart  during
ollow-up  period.
To  treat  cardiac  sarcoidosis,  we  added  prednisolone  to
er  medication  for  heart  failure.  As  above,  steroid  therapy
s  reported  to  prevent  progression  of  sarcoidosis  and  improve
urvival  rates  [5].  In  fact,  no  remarkable  exacerbation  was
hown  by  her  ECG  and  echocardiographic  data  during  these  3
ears.  On  the  other  hand,  it  also  has  harmful  side  effects  of
ater  and  salt  retention  on  heart  failure.  Moreover,  it  does
ot  seem  to  reduce  the  incidence  of  ventricular  arrhythmias
11].  So,  even  after  induction  of  this  therapy,  close  outpa-
ient  observation  was  required  to  prevent  worsening  of  heart
ailure  or  sudden  cardiac  death.
In  conclusion,  this  case  emphasizes  that  some  patients
ith  cardiac  sarcoidosis  have  no  any  other  extracardiac  fea-
ures.  It  is  supposed  to  be  a  relatively  rare  case,  not  due
o  low  morbidity  but  lack  of  appropriate  strategy  to  detect
atent  patients.  Recently,  novel  guidelines  for  diagnosis  and
reatment  of  myocarditis  were  published,  which  highlighted
ardiac  sarcoidosis  as  one  speciﬁc  type  of  myocarditis,  and
he  value  of  cardiac  MRI  as  an  effective  means  of  diagnosis
12].  Further  efforts  are  required  to  reveal  this  lethal,  but
reventable  disease.
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